Tumor suppressor candidate 1 (TUSC1) drives oxidative phosphorylation and tumor cell death in colorectal cancer
Janvie Manhas(All India Institute of Medical Sciences), Jayanth Kumar Palanichamy(All India Institute of Medical Sciences), Sudip Sen(All India Institute of Medical Sciences), Archna Singh(All India Institute of Medical Sciences), Ramani Shyam Kapuganti(All India Institute of Medical Sciences), S.V.S. Deo(DR. B.R.A. Institute Rotary Cancer Hospital), Priyanka Mani(All India Institute of Medical Sciences), Sagar Tyagi(All India Institute of Medical Sciences), Diksha Joshi(All India Institute of Medical Sciences), Anushree Bharadwaj(Regional Centre for Biotechnology), Jaydeep Sharma(Regional Centre for Biotechnology), Ruchi Bhardwaj(All India Institute of Medical Sciences), Gunjan Sharma(All India Institute of Medical Sciences), Prasenjit Das(All India Institute of Medical Sciences), Rajinder Parshad(All India Institute of Medical Sciences), Ayushi Jain(All India Institute of Medical Sciences), Sam J. Mathew(Regional Centre for Biotechnology)
Cited by 0
Related Papers
SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma
|Cell Death and Disease|2018|30
De novo variants in an extracellular matrix protein coding gene, fibulin-5 (FBLN5) are associated with pseudoexfoliation
|European Journal of Human Genetics|2019|26
Epigenetic silencing of heat shock protein 70 through DNA hypermethylation in pseudoexfoliation syndrome and glaucoma
|Journal of Human Genetics|2020|19
Current understanding of genetics and epigenetics in pseudoexfoliation syndrome and glaucoma
|Molecular Aspects of Medicine|2023|15
Musculoskeletal defects associated with myosin heavy chain‐embryonic loss of function are mediated by the YAP signaling pathway
|EMBO Molecular Medicine|2023|12